Overview
Asthma is a reversible airway disease.
Recurrent episodes of dyspnoea, cough, and wheeze
Caused by reversible airway obstruction.
Asthma has 3 contributory factors:
bronchial smooth muscle contraction
mucosal swelling/inflammation
increased mucus production
All these factors result in airway narrowing.
|
Symptoms
Dyspnoea or shortness of breath --- Intermittent
wheeze, cough (often nocturnal)
Diurnal variation -- symptoms vary over day,
Marked morning dipping of peak flow can occur
Precipitants: Cold air, exercise, allergens -- dust, pollen, mites
History of family history of atopy
Drugs: Aspirin, B-blockers
Occupational Asthma
are symptoms better on days away from work?
are symptoms better when on holiday/vacation?
Drug-Induced Asthma
Aspirin
B-blocker
Signs
Tachypnea
Audible wheeze, Hyperresonant, Hyperinflated, widespread polyphonic wheeze
Severe attack:
unable to complete sentences
PR>110, RR>25, PEF 33-50% predicted
Life-threatening Attack
confusion, exhaustion, cyanosis PaO2<60mmHg
silent chest, bradycardia
PEF < 33%
PaCO2 in Asthma
Mostly Normal
Life-threatening Attack
confusion, exhaustion, cyanosis
PaO2<60mmHg
PaCO2 is normal 35 - 45 mmHg
Near-Fatal
Increased PaCO2
Tests
Spirometry
Bronchodilator Reversibility BDR
FE NO -- Fractional Exhaled Nitric Oxide
Peak Flow Variability
Direct Bronchial Challenge Test with Histamine or Methacholine
Non Diagnostic Tests
Skin Prick Tests
Serum total and specific IgE
Eosinophil count
Exercise challenge (adults age 17 and over)
Do not use these tests to diagnose asthma
Tests Types
Airway Inflammation
FE NO -- Fractional Exhaled Nitric Oxide
Lung Function
Spirometry
Bronchodilator Reversibility BDR
Peak Flow Variability
Airwar Hyperreactivity
Direct Bronchial Challenge Test with Histamine or Methacholine
Diagnostic Tests of Asthma
Spirometry
Obstructive lung disease
↓↓FEV1, ↓FVC ---> ↓FEV1/FVC
FEV1/FVC ratio less than 70%
FeNO test Fractional Exhaled Nitric Oxide
FeNO level of 40 parts per billion (ppb) or more is considered as a positive test, and 35 ppb or more in children and young adults
Bronchodilator Reversibility BDR
Improvement in FEV1 after B-agonist or steroid trial
Improvement of 12% or more in BDR
Peak Flow Variability
Monitor peak flow variability over 2-4 weeks in those with diagnostic uncertainty
Peak flow variability of >20% is a positive test
Direct Bronchial challenge Test with Histamine/Methacholine
the provocative concentration of methacholine causing >20% drop in FeV1 aka PC20 value of 8mg/ml or less
Asthma Tests Summary
Acute Asthma: Treat immediately and test only if testing does not impair treatment or after symptoms have resolved
Age < 5: Treat based on Clinical Judgement
Age 5-16: Spirometry and BDR, FeNO +/- PEF variability if uncertain
Age 17 or more: Spirometry +/- BDR and FeNO, and PEF if uncertain
Asthma Diagnostic Tests Criteria Summary
Spirometry
FEV1/FVC less than 70%
Bronchodilator Reversibility BDR
>=12% improvement
FE NO -- Fractional Exhaled Nitric Oxide
>=40 ppb
Peak Flow Variability >=20%
Direct Bronchial Challenge Test with Histamine or Methacholine PC20 value <=8mg/mL
Differential Diagnosis of Asthma
Pulmonary Oedema aka Cardiac Asthma
COPD
Large airway Obstruction by FB, Tumor
SVC Obstruction
Pneumothorax
PE
Bronchiectasis
Lower Probability of Asthma Predictors
Cardiac Disease, prominent dizziness, lightheadedness, tingling
Chronic productive cough with no wheeze, significant smoking history >20 pack year
Change in voice
Normal examination when symptomatic, Normal PEF when symptomatic
Symptoms with cold only
Comments
Post a Comment